What conditions does Rise Therapeutics LLC run trials for?

In our tracked recruiting trials, Rise Therapeutics LLC sponsors trials for Adenoma, Arthritis, Rheumatoid, Basal Cell Cancer.

Clinical trials sponsored by Rise Therapeutics LLC

Recruiting trials

Conditions studied

Phase 1 3

Condition	Trials
Adenoma	1
Arthritis, Rheumatoid	1
Basal Cell Cancer	1
Melanoma	1
Rheumatoid arthritis	1
Solid Tumor	1
Solid Tumor, Adult	1
Squamous Cell Cancer	1
Ulcerative Colitis	1
Ulcerative Colitis Chronic	1
Ulcerative Colitis Chronic Mild	1
Ulcerative Colitis Chronic Moderate	1

R-2487 in Patients With Rheumatoid Arthritis
NCT05961592 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 6 locations
R-3750 in Patients With Mild to Moderate Ulcerative Colitis
NCT05666960 · Phase: Phase 1 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 5 locations
R-5780-01 In Combination With PD-1 Checkpoint Inhibitors (Checkpoint Protein on Immune Cells Called T Cells) in Patients With Solid Tumors
NCT06398418 · Phase: Phase 1 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 2 locations

Rise Therapeutics LLC is the lead sponsor of 3 recruiting trials.

No. For the full record, search ClinicalTrials.gov.